Subcutaneous Immunoglobulins Are a Valuable Treatment Option in Myasthenia Gravis
Journal of Clinical Neurology (Korea - South Korea
doi 10.3988/jcn.2018.14.1.98
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2018
Authors
Publisher
Korean Neurological Association (KAMJE)